Latin America Veterinary Vaccines Market Report and Forecast 2024-2032

Latin America Veterinary Vaccines Market Outlook

The market size for veterinary vaccines in Latin America reached a value of more than USD 400.77 million in 2023. The Latin America veterinary vaccines market is expected to grow at a CAGR of 6.50% between 2024 and 2032, reaching a value of USD 704.79 million by 2032. 

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Trends in the Market

Veterinary vaccines are prescribed and given to animals to improve their health and to prevent the occurrence and transmission of diseases. The different types of vaccines available for veterinary patients are recombinant, modified live virus, and killed virus. Vaccination to animals can also be given through their food or injected to them directly. 

Technological advancements such as invention of DNA technology and DNA vaccines have improved the health of animals. New immunisation technologies have been developed that has proved to be very efficient in veterinary vaccines, further fuelling the growth of the market. 

Animal owners are becoming aware of new veterinary vaccines as they are the most concerned about their animal’s health. Marking a key trend in the market, more and more people are adopting pets and investing in their vaccinations, supporting the growth of the Latin America veterinary vaccines market.  

Key players have been doing research and development to fuel the market growth which has led to the development of recombinant vaccines that have advantages such as non-exposure to the pathogen. Such developments help in the growth of the market. 

Market Analysis

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on vaccine type, the Latin America veterinary vaccines market can be divided into livestock vaccines, companion animal vaccines, and other types of vaccines. Livestock vaccines are further subdivided into porcine vaccines, bovine vaccines, and poultry vaccines, among others. Companion animal vaccines are subcategorised into canine vaccines, feline vaccines, and equine vaccines, among others.

On the basis of route of administration, the market is divided into oral, parenteral, and others. By distributional channel, the market is segmented into veterinary hospitals and clinics, pharmacies and drug stores, and online, among others. Based on country, the market is divided into Brazil, Mexico, Argentina, Peru, Columbia, Uruguay, Chile, Ecuador, Costa Rica, and the Dominican Republic, among others 

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the Latin America veterinary vaccines market covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.  

• Boehringer Ingelheim International GmbH

• Elanco Animal Health Inc.

• Zoetis Services LLC

• Biogenesis Bago SA

• Benten Biotech SRL

• Ourofino Animal Health

• VETANCO S.A.

• SANPHAR

• Compañía Cibeles SA

• König S.A

• Laboratorios Andoci S.A.

• Others

Market Share by Vaccine Type

Livestock vaccines are provided to animals such as cattle, pigs, and poultry, to protect them against illnesses and diseases. Sickness can quickly spread amongst livestock as they are kept together in large numbers, increasing the importance of vaccination and the livestock segment in the Latin America veterinary vaccines market. Lack of vaccination can also lead to increased death rates among livestock, hampering the sales and profits of owners, thereby increasing the demand for vaccinations. 

Companion animals such as dogs, cats, and horses are in close proximity to their owners, who often grow strong attachments to the companion animals. This strong attachment drives more pet owners to invest in vaccines for their pets, protecting them from various diseases especially those that are not curable. Vaccination is considered more economical and effective than treatment in many cases. 

Market Share by Route of Administration

Parenteral immunisation technique is the most often used means of providing vaccination to animals, including livestock and companion animals. There are three major types of parenteral immunisation, including intramuscular, subcutaneous, and intradermal. The accuracy and effectiveness of parenteral routes of administration has led to hold a leading share in the Latin America veterinary vaccines market. 

Oral immunisation is popular for companion animals where pet owners would like to prevent the stress of an injection on their pet. However, oral administration requires pet owners to be highly vigilant to ensure that the vaccine has been consumed properly. New techniques such as mucosal vaccination are expected to witness growth in the forecast period. 

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape 

Boehringer Ingelheim International GmbH founded in 1885 has its headquarter in Germany. It is a research-driven pharmaceutical company that deals with the health of both humans and animals. They discover, develop, manufacture, and then market their innovative products dedicated for healthcare. 

Elanco Animal Health Inc. is a pharmaceutical company that was established in 1954 and has its headquarters in Indiana, United States. It is an American company which manufactures and supplies medicines and vaccines for pets and farm animals. 

Zoetis Services LLC established in 1952 is based out of New Jersey, United States. It is an animal health company that provide their customers with quality vaccines, diagnostic products, and medicines along with a range of other services. 

Other market players include Biogenesis Bago SA, Benten Biotech SRL, Ourofino Animal Health, VETANCO S.A., SANPHAR, Compañía Cibeles SA, König S.A, and Laboratorios Andoci S.A., among others.

Key Highlights of the Report